5-hydroxydecanoate has been researched along with lipid a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, GT; Gross, GJ; Mei, DA | 1 |
| Elliott, GT; Hoag, JB; Janin, Y; Kukreja, RC; Qian, YZ | 1 |
2 other study(ies) available for 5-hydroxydecanoate and lipid a
| Article | Year |
|---|---|
Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
Topics: Adenosine Triphosphate; Animals; Blood Gas Analysis; Blood Pressure; Coronary Circulation; Decanoic Acids; Dogs; Female; Glyburide; Heart Rate; Hydrogen-Ion Concentration; Hydroxy Acids; Hypoglycemic Agents; Lipid A; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardial Stunning; Potassium Channel Blockers; Potassium Channels; Ventricular Function, Left | 1998 |
Pharmacologic preconditioning with monophosphoryl lipid A is abolished by 5-hydroxydecanoate, a specific inhibitor of the K(ATP) channel.
Topics: Adenosine Triphosphate; Animals; Decanoic Acids; Hemodynamics; Hydroxy Acids; Ischemic Preconditioning; Lipid A; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Potassium Channel Blockers; Rabbits | 1998 |